Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
International Review of Cell and Molecular Biology|July 7, 2025
Gut microbiome and tumor immunotherapyMohini Vig, Shweta DubeyBiochemistry and Biophysics Reports|July 11, 2025
Altered dynamics of T cell subsets in peripheral blood impacts disease progression in newly diagnosed multiple myelomaMohini Vig, Lalit Kumar, Shweta Dubey, et al.Annals of Translational Medicine|September 21, 2020
Metabolic reprograming of tumor-associated macrophagesAbhishek Puthenveetil, Shweta DubeyCytokine|July 13, 2023
IL-22 as a target for therapeutic intervention: Current knowledge on its role in various diseasesPranav Seth, Shweta DubeyAnnals of Hematology|April 9, 2005
Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemiaShweta Dubey, Priyanka Shukla, Soniya NityanandDiabetes & Metabolic Syndrome|August 5, 2018
Role of immunological markers in gestational diabetes mellitus-a brief reviewSamreen Siddiqui, Swati Waghdhare, Sujeet Jha, et al.Preparative Biochemistry & Biotechnology|January 23, 2018
Immunotherapy approach with recombinant survivin adjuvanted with alum and MIP suppresses tumor growth in murine model of breast cancerHimani Garg, Jagdish C Gupta, G P Talwar, et al.Cureus|April 27, 2026
Low-Velocity Penetrating Cranial Trauma With a Retained Axe: Surgical Management and Operative Challenges in a Civilian Assault CaseJason Golmei, Shubham Kaushal, Hanuman Prasad, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieuAnagha A Divekar, Shweta Dubey, Pallavi R Gangalum, et al.Cancer Cell International|June 25, 2016
Survivin: a unique target for tumor therapyHimani Garg, Prerna Suri, Jagdish C Gupta, et al.Pageof 2